aripiprazole has been researched along with cannabidiol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Amada, N; Deiana, S; Kikuchi, T; Riedel, G; Stott, C; Watanabe, A; Yamasaki, Y | 1 |
Campos, AC; Costa, KCM; Crippa, ACS; Crippa, JAS; Del-Bel, EA; Ferreira, FR; GuimarĂ£es, FS; Hallak, JEC; Lima, DA; Pedrazzi, JFC; Silva-Amaral, D; Zuardi, AW | 1 |
1 review(s) available for aripiprazole and cannabidiol
Article | Year |
---|---|
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Cannabidiol; Child, Preschool; Endocannabinoids; Humans | 2022 |
1 other study(ies) available for aripiprazole and cannabidiol
Article | Year |
---|---|
MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol.
Topics: Animals; Aripiprazole; Benzodiazepines; Cannabidiol; Dizocilpine Maleate; Dopamine Antagonists; Male; Memory; Models, Animal; Olanzapine; Rats; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Risperidone; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Social Behavior | 2015 |